VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant modelsDa Long(Roche (Switzerland)), Peter A. Campochiaro(Johns Hopkins University)JCI InsightMay 16, 201810.1172/jci.insight.120231Cited by 27SaveCiteExport RISWatch citationsRelated PapersAnti-angiogenic collagen IV-derived peptide target engagement with αvβ3 and α5β1 in ocular neovascularization models|iScience|2023|12